Imiquad Cream 0.5%
Activates your immune system directly at the site of application to recognize and clear abnormal skin cell growths.
Glenmark Pharmaceuticals is an established Indian pharmaceutical company with a diverse global footprint. The company maintains a strong focus on specialty therapeutic areas, including dermatology, respiratory health, and oncology, while producing a wide range of generic formulations. Three of their dermatological formulations are included in the product catalog listed here.
Activates your immune system directly at the site of application to recognize and clear abnormal skin cell growths.
Accelerates skin cell turnover to clear blocked pores, fade acne marks, and smooth surface skin texture.
Regulates skin cell turnover to clear blocked pores and address excessive cell pile-up in dermatologic conditions.
Glenmark Pharmaceuticals operates as a research-led, integrated global pharmaceutical organization. With a heritage spanning several decades, the company has developed a presence in various international markets, delivering accessible treatment options for common and complex health conditions. They maintain manufacturing facilities that adhere to international regulatory requirements for global distribution.
The company is widely recognized for its expertise in dermatological research and innovative drug delivery systems. Beyond skin care, Glenmark’s therapeutic focus includes management of respiratory conditions and metabolic disorders. Their operational model emphasizes the development of complex generics, allowing them to provide alternative, lower-cost versions of established medications to patients and healthcare systems worldwide.
The current catalog focuses on Glenmark’s specialty in dermatological treatments. These products address various skin conditions, utilizing well-established active ingredients to ensure consistency in therapy. Examples of these formulations include Imiquad Cream 0.5%, used for specific dermatological applications, and topical retinoid treatments such as Revize Micro 0.025% Gel and Tazret Forte Cream 0.1%.
These products are manufactured to meet standards for stability and dermal absorption, serving patients who require targeted treatment for chronic or acute skin issues. The catalog represents a small segment of the company’s broader dermatological portfolio, which is prescribed by medical professionals globally.
These products are generic pharmaceutical formulations manufactured by Glenmark Pharmaceuticals. Individual products differ in active ingredient, formulation, strength, and intended use. This page is a product catalog; it is not medical advice or an endorsement of specific products. Readers should review individual product labeling and consult a healthcare professional for guidance on which product suits their needs.